Quick Answer
Anixa Biosciences Inc reported Stockholders Equity of $15.16 million for fiscal year 2025.
Anixa Biosciences Inc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $15.16M | -24.2% |
| 2024 | $20.00M | -17.8% |
| 2023 | $24.34M | -16.2% |
| 2022 | $29.05M | -18.0% |
| 2021 | $35.44M | +304.5% |
| 2020 | $8.76M | +67.3% |
| 2019 | $5.24M | -3.7% |
| 2018 | $5.43M | -31.4% |
| 2017 | $7.92M | +702.3% |
| 2016 | $987.5K | -80.5% |
| 2015 | $5.05M | +26.0% |
| 2014 | $4.01M | +220.7% |
| 2013 | -$3.32M | -178.1% |
| 2012 | -$1.19M | -212.9% |
| 2011 | $1.06M | -77.0% |
| 2010 | $4.60M | +3.2% |
| 2009 | $4.45M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $15.08M | -15.5% | -0.6% |
| October 31, 2025 | $15.16M | -24.2% | -8.6% |
| July 31, 2025 | $16.59M | -23.8% | +3.3% |
| April 30, 2025 | $16.07M | -32.0% | -10.0% |
| January 31, 2025 | $17.85M | -27.4% | -10.7% |
| October 31, 2024 | $20.00M | -17.8% | -8.1% |
| July 31, 2024 | $21.77M | -14.7% | -7.8% |
| April 30, 2024 | $23.62M | -11.9% | -4.0% |
- Anixa Biosciences Inc showed a decrease of -24.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, Anixa Biosciences Inc’s stockholders equity has grown by 240.5% (from $4.45 million to $15.16 million).
- The most recent figure is from Anixa Biosciences Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: